A course of 8-week IL-4 supplementation improves common phenotypes of obesity and impaired signaling pathways of Akt, STAT3, and STAT6 in the hypothalamic, hepatic, and epididymal fat tissues. Here, IL4 is linked to obesity due to melanocortin 4 receptor deficiency.